Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the ...
Feb 8, 2012
0
0
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...
Jan 30, 2023
0
59
Signals from the immune system that help repel a common parasite inadvertently can cause a dormant viral infection to become active again, a new study shows.
Jun 26, 2014
1
5
The chemotactic protein CCL17 attracts immune cells to where they are needed. Doctors have long known that a high level of CCL17 in the body indicates an allergic reaction. Researchers led by the University of Bonn have now ...
Sep 13, 2018
0
23
A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in ...
Oct 17, 2017
0
67
Mast cell precursor cells do not just cause an increase in mature mast cells during inflammation, they also play an active role in diseases like asthma. This finding is in a new study by immunology researchers published in ...
Sep 27, 2021
0
66
Transplantation of a whole pancreas or isolated insulin-producing beta cells are the only therapy to cure type I diabetes. However, the shortage of organ donors limits this approach to only few patients. LMU researchers have ...
Apr 23, 2012
1
0
Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can be found that ...
Dec 17, 2014
0
0
Australian researchers are a step closer to understanding immune sensitivities to well-known, and commonly prescribed, medications.
Feb 6, 2017
0
51
A cytokine 'hurricane' centered in the lungs drives respiratory symptoms in patients with severe COVID-19, a new study by immunologists at Columbia University Vagelos College of Physicians and Surgeons suggests.
Mar 15, 2021
0
216
